- Global Pharma News & Resources

Global Anesthesia Drugs Market by Drug Type, Route of Administration, Application and Geography - Forecast to 2023 -

The "Global Anesthesia Drugs Market - Segmented by Drug Type, Route of Administration, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to's offering.

The global anesthesia drugs market is expected to register a CAGR of 3.5% during the forecast period (2018-2023).

Rise in the Number of Surgeries

According to the Center for Disease Control and Prevention (CDC), the total number of inpatient surgeries performed in the United States grew from 48 million in 2009 to 51.4 million in 2010, with cardiology, surgical, and obstetrical procedures being the most common ones. The number of surgeries being performed is rising every year.

The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as anesthetic drugs are used in surgical procedures to reduce the pain during surgery. Along with rising surgeries, other factors such as new anesthetic drugs and reduction in the cost of newly invented drugs are also driving the market.

Side Effects of General Anesthesia

Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient's reluctance towards using it, along with lack of skilled anesthetics and regulatory issues are restraining the market growth.

Market Dynamics


  • Increasing Number of Surgeries
  • New Approvals of Anesthetic Drugs
  • Reduction in the Cost of Newly Invented Drugs


  • Side-Effects of General Anesthetics
  • Lack of Skilled-Anesthetics
  • Regulatory Issues

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Baxter Healthcare
  • Hospira
  • Abbott Laboratories
  • Astra Zeneca
  • Roche Holding AG
  • B. Braun Melsungen AG
  • AbbVie
  • Boehringer Ingelheim
  • Eisai
  • Fresenius SE & Co. KGaA

For more information about this report visit

View source version on

Editor Details

Last Updated: 23-Jan-2019